H&R GmbH & Co. KGaA

  • WKN: A2E4T7
  • ISIN: DE000A2E4T77
  • Land: Deutschland

Nachricht vom 27.07.2021 | 11:17

H&R GmbH & Co. KGaA supports Green Hydrogen initiative AquaVentus

DGAP-News: H&R GmbH & Co. KGaA / Key word(s): Sustainability/Alliance
27.07.2021 / 11:17
The issuer is solely responsible for the content of this announcement.

H&R GmbH & Co. KGaA becomes a sponsoring partner of the AquaVentus initiative

- H&R strengthens the Green Hydrogen initiative; at the same time, the company is implementing another building block for its own sustainability strategy

- Diversification of access options to additional quantities of Green Hydrogen; company brings expertise as the operator of one of the largest flexible electrolysis plant

Salzbergen, Germany, July 27th, 2021. H&R GmbH & Co. KGaA has joined the AquaVentus development association and thus supports this Green Hydrogen Initiative, which now consists of roughly 65 internationally leading companies, organizations and research institutions. "AquaVentus has set itself the goal of installing ten gigawatts of electrolysis power from offshore wind energy in the North Sea by 2035", explains Detlev Wösten, Chief Sustainability Officer at H&R. The offshore wind power will be used to generate green hydrogen on the high seas and then bring it to shore via pipeline. The members of the initiative bundle many years of expertise in the core area of ​​hydrogen generation and utilization, in the fields of economic development, offshore energy generation, pipeline maintenance as well as port logistics and transport. The sub-projects related to the AquaVentus initiative include various modules along the entire hydrogen value chain: from the generation of hydrogen in the North Sea to transport to customers on the mainland and a rapid market ramp-up. These include, for example: the development of offshore wind energy plants with integrated hydrogen generation, a large-scale offshore hydrogen park, a central supply pipeline, port infrastructures, maritime hydrogen-based applications and research platforms. "Our membership at AquaVentus is a step in the implementation of our sustainability strategy. The chemical industry will change fundamentally within the next decade and we want to ensure constant access to extensive amounts of green hydrogen in order to convert our product portfolio. With our already existing hydrogen electrolysis know-how, our initiatives for the production of our own synthesis products and through our networking with the major hydrogen players of the future, we will underpin our claim to leadership in the further development of PtX technologies and climate-friendly product solutions and thus want to contribute significantly to the achievement of the societal climate goals", says H&R's managing director and CEO Niels H. Hansen.

Contact information:
H&R GmbH & Co. KGaA, Head of Investor Relations/Communications, Ties Kaiser
Neuenkirchener Strasse 8, 48499 Salzbergen
Tel.: +49 40 43218-321, Fax: +49 40 43218-390
e-mail: ties.kaiser@hur.com ; www.hur.com

H&R GmbH & Co. KGaA:
H&R KGaA is a specialty-chemicals company listed on the Frankfurt Stock Exchange's Prime Standard segment. It develops and manufactures crude-oil-based chemical and pharmaceutical specialty products and produces high-precision plastic parts.

Forward-looking statements and forecasts:
This press release contains forward-looking statements. The statements are based on the current estimates and forecasts by the Executive Board and the information available to the Board at this time. These forward-looking statements do not provide any warranty for the future developments and results contained therein. The future developments and results are dependent on a number of factors; they entail various risks and contingencies and are based on assumptions which could prove to be incorrect. We do not assume any responsibility for updating the forward-looking statements contained in this press release.

27.07.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Infineon Technologies AG: Aufsichtsrat beruft Jochen Hanebeck zum Nachfolger von Dr. Reinhard Ploss als Vorstandsvorsitzenden von Infineon

25. November 2021, 17:45

Aktuelle Research-Studie


Original-Research: 3U HOLDING AG (von GSC Research GmbH): Halten

26. November 2021